SUNLENCA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Gilead Sciences Ireland Unlimited Company🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: ec1c1b40c3dac998
Drug Cima Aemps Name: SUNLENCA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1221671001
Holder Company Name: Gilead Sciences Ireland Unlimited Company
Marketing Company Name: Gilead Sciences S.L.
Holder Company Detail Path: /organization/gilead-sciences-ireland-unlimited-company
Authorization Date: 2022-09-16
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 300 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Gilead Sciences Ireland Unlimited Company
Company Detail Path: /organization/gilead-sciences-ireland-unlimited-company

LENACAPAVIR SODIO

306,8 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 16, 2022

Approval ID

ec1c1b40c3dac998

Type

Standard